The U.S. Food and Drug Administration approved the pill for weight loss earlier this month, intensifying Lilly's competition with rival Novo Nordisk.

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...

A monthly out-of-pocket cap on insulin for Medicare beneficiaries with type 2 diabetes is linked to some clinical benefits as ...

Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...

The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections.

Highly unstable under heat: When exposed to high temperatures (such as during frying), the PUFAs in seed oils break down and ...

Read more from STAT contributor Brianna Abbott on the popular vote winner. And STAT’s Amanda Erickson, who edits this very newsletter, has a dispatch on the research our editors chose as the best ...

A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week would cap the cost of the lifesaving drug at $35 per month for people with ...

If the pancreas can no longer manage high blood sugar (hyperglycemia), significant, long-term health issues can arise.

Current evidence does not allow firm conclusions regarding the safety of treatment with insulin-like growth factor-1, a protein that helps blood vessels in the retina of the eye grow normally, in ...